A Novel Anticancer Ribonucleoside, 1-(3-C-Ethynyl-β-<scp>D</scp>-ribo-pentofuranosyl)Cytosine, Enhances Radiation-Induced Cell Death in Tumor CellsOsamu Inanami, Mikinori Kuwabara, Kenji Kitazato et al.|Radiation Research|2004Cited by 16
A Novel Anticancer Ribonucleoside, TAS106 Radiosensitizes Apoptosis through Survivin Down-regulation and G2/M Checkpoint Abrogation in MKN45 CellsOsamu Inanami, Mikinori Kuwabara, Kenji Kitazato et al.|The Japan Radiation Research Society Annual Meeting Abstracts The 46th Annual Meeting of The Japan Radiation Research Society|2003Cited by 0
A novel anticancer ribonucleoside, TAS106, switches necrosis to apoptosis in x-irradiated MKN45 cells through survivin down-regulation and G2/M checkpoint abrogationOsamu Inanami, Kaio Kitazato, Akiko Iwahara et al.|OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)|2003Cited by 0
A novel anticancer ribonucleoside, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells.Osamu Inanami, Mikinori Kuwabara, Daisuke Iizuka et al.|Institutional Repositories DataBase (IRDB)|2004Cited by 0